Universal Health Realty Income Trust (UHT) 股票分析

公司概述

Universal Health Realty Income Trust operates as a real estate investment trust dedicated to acquiring and managing healthcare and human-service related facilities, which include acute care hospitals, behavioral health care hospitals, specialty facilities, medical and office buildings, free-standing emergency departments, and childcare centers. This business model places the entity squarely within the Real Estate sector, specifically the REIT - Healthcare Facilities industry, where it generates income primarily through leasing agreements with healthcare providers rather than direct patient care. The company currently maintains a market capitalization of $584.40M and reports an annual revenue of $100.89M over the trailing twelve months, while the specific employee count is not disclosed in available records. These valuation and revenue figures indicate that Universal Health Realty Income Trust functions as a mid-sized player in the specialized healthcare real estate market, possessing sufficient scale to support significant debt obligations yet remaining sensitive to the broader economic cycles affecting the healthcare infrastructure sector.

财务健康

The company reported a revenue of $100.89M and a net income of $17.61M for the trailing twelve months, with an EBITDA of $66.05M, revealing a substantial gap between operating earnings and bottom-line profit that highlights a heavy cost structure involving taxes, interest expenses, and other operational deductions. Despite generating robust operating earnings, the entity maintains a free cash flow of $45.65M, which provides essential financial flexibility to service its debt load and potentially fund future acquisitions or operational improvements without relying solely on external financing. The company demonstrates exceptional efficiency in revenue generation with a gross margin of 94.5%, while the operating margin stands at 39.6% and the profit margin is 17.5%, indicating that while operating costs are controlled, significant expenses below the operating level reduce the final profitability to investors. On the balance sheet, cash holdings of $8.29M are significantly outweighed by total debt of $386.03M, resulting in a debt-to-equity ratio of 253.33, which characterizes the capital structure as highly leveraged and dependent on stable cash flows to meet interest obligations. Liquidity management appears strong with a current ratio of 7.80, suggesting ample short-term assets relative to liabilities to cover immediate obligations comfortably. Return on equity is calculated at 10.6% while return on assets is 4.1%, metrics that collectively reveal that management effectiveness is optimized for equity holders but faces inherent challenges in generating returns on the total asset base due to the high leverage employed.

估值评估

The trailing twelve-month P/E ratio is 33.17, while the forward P/E ratio is not available in current data, a discrepancy that implies uncertainty regarding future earnings trajectories or a lack of analyst consensus on forward-looking earnings estimates for this specific REIT. The price-to-book ratio stands at 3.84, indicating that the market values the company's equity at a significant premium over its tangible book value, reflecting the quality of its underlying healthcare real estate assets and stable lease contracts. Alternative valuation metrics further contextualize the stock's price, with a price-to-sales ratio of 5.79 and an EV/EBITDA of 14.57, suggesting that the market is willing to pay a high multiple for its sales and earnings relative to the broader real estate sector averages. Price action analysis shows a 52-week high of $44.70 and a 52-week low of $35.26, providing a defined trading range within which the current market price must be situated relative to recent volatility extremes. The beta value of 0.89 indicates that the stock's price volatility is lower than the broader market, suggesting a slightly defensive characteristic typical of essential healthcare infrastructure assets that may experience less drastic price swings during market downturns compared to high-growth technology sectors.

Growth & Income

Revenue growth year-over-year is recorded at 0.0%, while earnings growth year-over-year is negative at -8.1%, implying that earnings are contracting faster than revenue or in absolute terms given the flat revenue base, likely driven by the aforementioned high cost structure or expense increases not fully offset by income. As a dividend-paying entity, Universal Health Realty Income Trust offers a dividend yield of 7.1%, but the payout ratio is 233.1%, a figure that exceeds the net income available to common shareholders and suggests that the dividend is being funded through capital distributions or debt service rather than organic earnings retention. This elevated payout ratio indicates a potential sustainability challenge, as the company must rely on non-operating cash flows or debt refinancing to maintain the current dividend level when earnings are declining. The overall growth and income profile presents a mixed picture where high current income distribution is supported by strong asset quality but lacks the earnings growth momentum necessary to sustain the dividend organically without leveraging the balance sheet further or reducing capital expenditures.